首頁 > 市場調查報告書 > 製藥

疫苗

人類DNA定量市場規模、佔有率和成長分析：按產品類型、技術、應用、最終用戶和地區分類－2026-2033年產業預測

市場調查報告書

商品編碼

2120168

人類DNA定量市場規模、佔有率和成長分析：按產品類型、技術、應用、最終用戶和地區分類－2026-2033年產業預測

Human DNA Quantification Market Size, Share, and Growth Analysis, By Product Type (Kits & Reagents, Instruments), By Technology (qPCR, Fluorometry), By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2026年08月02日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2024 年全球人類 DNA 定量市場價值為 21.8 億美元，預計到 2025 年將成長至 23.7 億美元，到 2033 年將成長至 45.8 億美元，在預測期（2026-2033 年）內複合年成長率為 8.6%。

在全球監管標準日益嚴格的背景下，臨床診斷對精準DNA檢測的需求不斷成長，推動全球人類DNA定量市場預計將顯著成長。監管機構強制要求進行DNA定量檢驗，以確保結果的可重複性，促使檢查室轉向基於螢光的自動化系統，這些系統整合了樣本追蹤和雲端分析功能。在腫瘤學領域，伴隨診斷試劑盒的興起凸顯了準確性的重要性，因為醫院需要更先進的定量解決方案。為此，供應商正在加強研發力度，開發多重檢測試劑盒，以增強DNA定量技術的性能，滿足不斷變化的市場需求，並改善患者的治療效果。

全球人類DNA定量市場促進因素

高通量定序技術的進步顯著提高了檢查室DNA定量分析的效率和速度，使其能夠在不中斷常規操作的情況下進行。這項技術進步使得即使面對大檢體也能實現高精度測量，從而使定量分析更具吸引力。此外，定量分析對於臨床醫生至關重要，因為它提供了做出明智決策所需的關鍵數據，從而推動了對可靠定量平台的需求。為了滿足這些日益成長的需求，製造商正致力於產品創新以適應不斷變化的需求，最終推動全球人類DNA定量市場的擴張。

全球人類DNA定量市場的限制因素

全球人類DNA定量市場受到嚴格法規結構的約束，這構成了一項重大挑戰，因為它要求對DNA定量工具進行全面的檢驗和文件記錄。企業在獲得不同司法管轄區營運所需的認證方面面臨著巨大的財務負擔。此外，監管標準的頻繁更新需要對硬體和軟體組件進行修改，從而分散了企業用於推動成長和創新的資源和精力。因此，這些障礙構成了重大阻礙，尤其對中小企業而言，可能會妨礙它們跟上技術進步的步伐，並在競爭激烈的市場環境中有效部署創新解決方案。

人類DNA定量市場的全球趨勢

在全球高解析度DNA定量技術進步的推動下，人類DNA定量市場正朝著精準腫瘤學工作流程的整合方向發展。這一轉變使臨床醫生能夠更準確地評估腫瘤負荷和異質性，從而製定個人化的治療方案。定量檢測擴大被納入診斷組合，這增強了決策流程和患者分層能力。推動這一趨勢的因素包括：人們對檢測結果可重複性的信心增強、生物標記類型的擴展，以及全球醫療系統對可靠數據輸入日益成長的需求，以支持免疫療法和標靶藥物療法的開發和應用。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太國家
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲國家
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲國家

競爭資訊

前五大公司對比
主要公司2025年的市場定位
主要市場公司採取的策略
近期市場趨勢
企業市場占有率分析，2025 年
主要公司的完整公司簡介
- 公司詳情
- 產品系列分析
- 按細分市場進行企業市佔率分析
- 銷售收入年比比較（2023-2025 年）

主要公司簡介

Thermo Fisher Scientific Inc.
QIAGEN NV
F. Hoffmann-La Roche Ltd.
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Danaher Corporation
Promega Corporation
Merck KGaA
PerkinElmer, Inc.
Takara Bio Inc.
Hamilton Company
LGC Limited
Analytik Jena GmbH
Tecan Group Ltd.
DiaSorin SpA
Illumina, Inc.
Standard BioTools Inc.
Oxford Nanopore Technologies plc
Revvity, Inc.
Norgen Biotek Corp.

結論與建議

簡介目錄

Product Code: SQMIG35J2678

Global Human Dna Quantification Market size was valued at USD 2.18 Billion in 2024 and is poised to grow from USD 2.37 Billion in 2025 to USD 4.58 Billion by 2033, growing at a CAGR of 8.6% during the forecast period (2026-2033).

The global human DNA quantification market is poised for significant growth driven by the increasing demand for precise DNA input in clinical diagnostics, fueled by stringent regulatory standards. Regulatory bodies require validation of DNA quantities to ensure reproducibility of results, pushing laboratories toward automated fluorescence-based systems that incorporate sample tracking and cloud-based analysis. The oncology sector has highlighted the importance of accuracy, as the rise of companion diagnostic panels has prompted hospitals to seek advanced quantification solutions. In response, vendors are intensifying their research and development efforts to create multiplexing kits, enhancing the capabilities of DNA quantification technologies to meet evolving market needs and improve patient outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Human Dna Quantification market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Human Dna Quantification Market Segments Analysis

Global human dna quantification market is segmented by product type, technology, application, end user and region. Based on product type, the market is segmented into Kits & Reagents, Instruments and Software. Based on technology, the market is segmented into qPCR, Fluorometry and Spectrophotometry. Based on application, the market is segmented into Forensic Testing, Clinical Diagnostics, Research and NGS Sample Preparation. Based on end user, the market is segmented into Diagnostic Laboratories, Research Institutes and Forensic Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Human Dna Quantification Market

The advancement of high-throughput sequencing technology has significantly enhanced the efficiency and speed of DNA quantification in laboratories, enabling routine practices to occur without interruptions. This technological progress allows for high accuracy in measuring large sample sizes, making the quantification process increasingly appealing. Moreover, quantitative analysis is crucial for clinicians, as it provides vital data necessary for informed decision-making, thereby driving the demand for dependable quantification platforms. In response to this growing necessity, manufacturers are focused on innovating their products to meet these evolving requirements, ultimately supporting the expansion of the Global Human DNA Quantification market.

Restraints in the Global Human Dna Quantification Market

The stringent regulatory frameworks governing the Global Human DNA Quantification market present significant challenges, as they mandate exhaustive validation and documentation processes for DNA quantification tools. Organizations face considerable financial burdens related to obtaining necessary certifications to operate across different jurisdictions. Additionally, frequent updates to regulatory standards require corresponding modifications to hardware and software components, diverting resources and attention away from advancing organizational growth and innovation. Consequently, these obstacles can be particularly daunting for smaller companies, impeding their ability to keep pace with technological advancements and to introduce novel solutions effectively within the competitive landscape.

Market Trends of the Global Human Dna Quantification Market

The Global Human DNA Quantification market is witnessing a shift towards the integration of precision oncology workflows, driven by advancements in high-resolution DNA quantitation technologies. This evolution enables clinicians to more accurately assess tumor burden and heterogeneity, leading to personalized treatment plans. The rising inclusion of quantitative testing within diagnostic panels enhances decision-making processes and patient stratification. Contributing factors to this trend include growing confidence in test reproducibility, an expanding array of biomarkers, and a heightened demand for robust data inputs to support the development and application of immunotherapy and targeted drug therapies across worldwide healthcare systems.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index 2025
PESTEL Analysis
Regulatory Landscape

Global Human DNA Quantification Market Size by Product Type & CAGR (2026-2033)

Market Overview
Kits & Reagents
Instruments
Software

Global Human DNA Quantification Market Size by Technology & CAGR (2026-2033)

Market Overview
qPCR
Fluorometry
Spectrophotometry

Global Human DNA Quantification Market Size by Application & CAGR (2026-2033)

Market Overview
Forensic Testing
Clinical Diagnostics
Research
NGS Sample Preparation

Global Human DNA Quantification Market Size by End User & CAGR (2026-2033)

Market Overview
Diagnostic Laboratories
Research Institutes
Forensic Laboratories

Global Human DNA Quantification Market Size & CAGR (2026-2033)

North America (Product Type, Technology, Application, End User)
- US
- Canada
Europe (Product Type, Technology, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Technology, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Technology, Application, End User)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Technology, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Promega Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hamilton Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LGC Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Analytik Jena GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tecan Group Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DiaSorin S.p.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Standard BioTools Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oxford Nanopore Technologies plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Revvity, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Norgen Biotek Corp.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments